Is Regional Anesthesia of the Hip Preferable Over Traditional Analgesia in the Acute Stage of the Management of Patients With a Fracture of the Hip

Status

Terminated

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01593319

Enrollment

Registered

2012-05-08

Start date

2012-01-31

Completion date

2015-04-30

Last updated

2015-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Fractures

Brief summary

The main hypothesis of the study is that anaesthesia of the hip using infiltration with a local anesthetic solution is preferable over traditional analgesia with oral opioid medications in the acute stage of the management of patients with a fracture of the hip. To study the hypothesis the investigators designed a prospective randomised study where patients are assigned in two groups, the first receiving local hip anesthesia and the other placebo treatment. Both groups are eligible to use of standard oral pain treatment. Effect of analgesia as well as medical complications will be recorded.

Interventions

DRUGRopivacaine

Local injection (fascia iliaca block) using 150 mg ropivacaine

DRUGNatrium chloride

Placebo injection of Natrium chloride solution

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Masking

QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

65 Years to No maximum

Healthy volunteers

Inclusion criteria

* fracture of the hip

Exclusion criteria

* multiple fractures, * delay (more than 12 hours) from the time of injury until admission to the hospital, * local infections, hypersensitivity to local analgetics, * cognitive impairment

Design outcomes

Primary

Measure	Time frame
Pain	3 hours

Secondary

Measure	Time frame
medical complications (Number of participants that develop pressure ulcers, number of participants that develop pneumonia)	under hospitalization (expected average of 10 days)

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026